Incidence rates (IRs) and hazard ratios (HRs) for symptomatic venous thromboembolism by increasing platelet count with 95% confidence intervals; The Tromsø Study 1994–2009.
收藏数据链接：
官方服务：
资源简介：
*109/L.†Person years. Subjects who develop cancer during follow-up are treated as non-cancer subjects until one year prior to the cancer diagnosis.‡Incidence per 1000 person years.Model 1: Adjusted for age and sex.Model 2: Adjusted for age, sex, body mass index, smoking, leukocyte count and mean platelet volume.Model 3: Model 2+ cancer stage (defined as localized or disseminated disease).
创建时间：
2015-12-02
